Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
The Journal of Molecular Diagnostics : JMD|March 30, 2021
Clinical Experience of Cerebrospinal Fluid-Based Liquid Biopsy Demonstrates Superiority of Cell-Free DNA over Cell Pellet Genomic DNA for Molecular ProfilingTejus A Bale, Soo-Ryum Yang, James P Solomon, et al.
The Journal of Molecular Diagnostics : JMD|November 20, 2020
Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing: Feasibility, Challenges, and Direct Comparison with High-Sensitivity Flow CytometryCaleb Ho, Mustafa Syed, Mikhail Roshal, et al.
The Journal of Molecular Diagnostics : JMD|March 25, 2015
Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular OncologyDonavan T Cheng, Talia N Mitchell, Ahmet Zehir, et al.
The Journal of Molecular Diagnostics : JMD|March 24, 2023
Clonal Characterization and Somatic Hypermutation Assessment by Next-Generation Sequencing in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Detailed Description of the Technical Performance, Clinical Utility, and Platform ComparisonKseniya Petrova-Drus, Mustafa Syed, Wayne Yu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 5, 2021
Comprehensive Molecular and Clinicopathologic Analysis of 200 Pulmonary Invasive Mucinous Adenocarcinomas Identifies Distinct Characteristics of Molecular SubtypesJason C Chang, Michael Offin, Christina Falcon, et al.
Acta Neuropathologica Communications|September 17, 2024
Real-world experience with circulating tumor DNA in cerebrospinal fluid from patients with central nervous system tumorsRichard A Hickman, Alexandra M Miller, Bridget M Holle, et al.
Haematologica|March 7, 2024
Cell-free DNA from nail clippings as source of normal control for genomic studies in hematologic malignanciesMelissa Krystel-Whittemore, Kseniya Petrova-Drus, Ryan N Ptashkin, et al.
JAMA|September 6, 2017
Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline TestingDiana Mandelker, Liying Zhang, Yelena Kemel, et al.
Nature Communications|October 29, 2023
Enhanced clinical assessment of hematologic malignancies through routine paired tumor and normal sequencingRyan N Ptashkin, Mark D Ewalt, Gowtham Jayakumaran, et al.
Nature Communications|June 19, 2021
Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESSA Rose Brannon, Gowtham Jayakumaran, Monica Diosdado, et al.
Pageof 9